Intended for healthcare professionals

  1. Research
  2. Comparison of...
  3. Comparison of treatment effects between animal experiments and clinical trials: systematic review
Research

Comparison of treatment effects between animal experiments and clinical trials: systematic review

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39048.407928.BE (Published 25 January 2007) Cite this as: BMJ 2007;334:197

Data supplement

  • References

    Files in this Data Supplement:

Related articles

See more

Cited by...

  • Activity of {beta}-Lactam Antibiotics against Metallo-{beta}-Lactamase-Producing Enterobacterales in Animal Infection Models: a Current State of Affairs
  • Embrace heterogeneity to improve reproducibility: A perspective from meta-analysis of variation in preclinical research
  • Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin
  • A novel mechanism of natural killer cell response to anti-CTLA-4 therapy identified by integrative analysis of mouse and human tumors
  • What influences treatment response in animal models of non-alcoholic fatty liver disease? A meta-analysis with meta-regression
  • Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease
  • Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?
  • An aged human heart tissue model showing age-related molecular and functional deterioration resembling the native heart
  • The druggable genome and support for target identification and validation in drug development
  • Bone marrow-on-a-chip: Emulating the human bone marrow
  • A standardised framework to identify optimal animal models for efficacy assessment in drug development
  • A urine-dependent human urothelial organoid offers a promising alternative to rodent models of infection
  • Flipping the odds of drug development success through human genomics
  • What is a 'complex systematic review? Criteria, definition, and examples
  • What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans?: Consideration of Strategies to Improve the Value of Animal Models
  • The Rising Cost of Developing Cardiovascular Therapies and Reproducibility in Translational Research: Do Not Blame It (All) on the Bench
  • Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation
  • The druggable genome and support for target identification and validation in drug development
  • Statistical Rigor and the Perils of Chance
  • Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity
  • The rat adequately reflects human responses to exercise in blood biochemical profile: a comparative study
  • Reproducibility in Science: Improving the Standard for Basic and Preclinical Research
  • Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease
  • Is animal research sufficiently evidence based to be a cornerstone of biomedical research?
  • Accelerating Translation of Physical Activity and Cancer Survivorship Research into Practice: Recommendations for a More Integrated and Collaborative Approach
  • A Concerted Appeal for International Cooperation in Preclinical Stroke Research
  • Extrapolating from Animals to Humans
  • Beyond Access vs. Protection in Trials of Innovative Therapies
  • Of Mice and Humans: Are They the Same?--Implications in Cancer Translational Research
  • Evaluating the causal relevance of diverse risk markers: horizontal systematic review
  • Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality
  • Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach
  • Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations
  • The study of rare diseases: butterfly collecting or an entree to understanding common conditions?
  • A broader view of animal research
  • Translating animal research into clinical benefit
Back to top